The Department of Health Care Services posted the following alerts on the Medi-Cal Rx Web Portal. Please note DUR Claims Edits were not reinstated on May 1 and the Electronic Claims Agreement Submission Deadline has been extended to July 31, 2022. Additionally, the Medi-Cal Rx 180-day prior authorization (PA) transition scheduled to go into effect July 1 will not take place. Medi-Cal Rx will continue to utilize historical PA and claims data beyond July 1. There is no new date for the transition. However, providers will be notified 90 days before the PA transition takes place.
- Diabetic Supplies – Therapeutic Continuous Glucose Monitoring (CGM) Systems (May 5)
- Medi-Cal Rx Operational Updates (May 5)
- Medi-Cal Rx Monthly Bulletin for May (May 1)
- Changes to Contract Drugs List (CDL) (May 1)
- Changes to Contract Drugs List (CDL) — Over-the-Counter Drugs (May 1)
- Updates to the Medi-Cal Rx Provider Manual (May 1)
- Update: Drug Utilization Review Claims Edits Will Not be Reinstated on May 1, 2022 (April 29)
- Electronic Claims Agreement – Submission Deadline Extended to July 31, 2022 (April 29)
- Medi-Cal Rx Weekly Wrap-Up for April 22-28 (April 29)
- Diabetic Supplies Update: Disposable Insulin Delivery Devices Updates (April 28)
- Medi-Cal Rx Compound Claims Processing Billing Tips (April 22)
- Prescriber Training Checklist (April 22)
- Pharmacy Training Checklist (April 22)
- Medi-Cal Rx Weekly Wrap-Up for April 15-21 (April 22)
- Medi-Cal Rx Billing Policy for Disposable Insulin Delivery Devices (April 21)
- Medi-Cal Rx Billing Policy for Continuous Glucose Monitoring Systems (April 21)
- Understanding Medi-Cal Rx for Beneficiaries (April 21)
Also in California, the Board of Pharmacy posted its agenda for the May 11 Board Meeting; see link below.
Finally in California, the Board of Pharmacy posted its May update.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.